Search company, investor...


Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$2.8M | 20 yrs ago

About Neoprobe

Neoprobe is a Healthcare/Medical Devices & Equipment company based in Dublin, Ohio. Neoprobe's investors include Sands Brothers Venture Capital, Bristol Capital Advisors, Bridges and PIPES, Alki Capital Management, Alpha Capital Partners, WEC Partners and Gamma Capital Partners.

Headquarters Location

425 Metro Place North Suite 300

Dublin, Ohio, 43017,

United States


Missing: Neoprobe's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Neoprobe's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Neoprobe News

2011 & Prior - Historical Transactions All Sectors

Nov 19, 2020

Home Market Pulses 2011 & Prior – Historical Transactions All Sectors Scotland-based Axis-Shield plc, diagnostic testing company Alere Inc. has picked up a smaller add-on, Arriva Medical, for $65 million. Private equity-backed Arriva of Coral Springs, Fla., operates a national mail-order distribution business of diabetes testing supplies, targeting patients who need to monitor blood glucose levels. The $65 million purchase price is 3 times the company’s $21.5 million in revenue for the six months ended Oct. 31. It also gives a quick exit to Palm Beach Capital LLC, with offices in West Palm Beach and Tampa, Fla., which said in May it bought a stake in Arriva for an undisclosed amount. The investment was made out of its Palm Beach Capital Fund III LP, which closed at the end of May with a total of $133.5 million. The fund typically invests between $3 million and $20 million in smallcap companies with Ebitda of between $3 million and $15 million. Alere’s purchase includes 806,452 restricted shares of Alere’s common stock, giving Arriva’s shareholders collectively less than 1% ownership in Alere. In October, Waltham, Mass.-based Alere won a hostile takeover of Axis-Shield in a deal worth £235 million ($364 million). Axis-Shield makes diagnostic products for a range of indications such as diabetes and blood coagulation. In February 2010, Alere, then known as Inverness Medical Innovations Inc., announced the acquisition of Kroll Laboratory Specialists Inc. and its two substance abuse testing laboratories for $110 million in cash. In September 2009, the company announced it would acquire Seattle healthcare coaching company Free & Clear Inc. for $100 million up front and $30 million more in milestones. As of Sept. 30, Ebitda in the first nine months stood at $379 million on $1.74 billion of revenue. The company had cash and cash equivalents of nearly $277 million. A group led by The Jordan Company has completed its sale of Wound Care Holdings to National Healing Corporation, a portfolio company of Metalmark Capital since 2008. Wound Care is a provider of wound care clinic management services to hospitals as well as a manufacturer of monoplace hyperbaric oxygen therapy chambers and other respiratory care products. TJC formed the company in 2006 in partnership with The Edgewater Funds and JZ Capital Partners. HCP & Company (fka Hispania Capital Partners) has acquired a majority interest in Polaris Hospital Company. Polaris acquires, develops and operates physical medicine/rehabilitation hospitals and behavioral health hospitals in cooperation with acute hospitals. The investment will serve as a platform for HCP to capitalize on the shortage it has identified in facilities to meet the growing demand for behavioral health services. Genetic testing instrument maker Affymetrix Inc. agreed to pay $330 million for eBioscience Inc. The San Diego-based target tapped Jefferies managing director Real Leclerc to facilitate the acquisition, which is expected to close late in the fourth quarter. The deal, announced Wednesday, Nov. 30, enhances the Affymetrix molecular diagnostics business and improves its focus on stem cell biology. Privately held eBioscience specializes in flow cytometry, which is used to study blood cells with the goal of researching and diagnosing diseases. The transaction will be financed using a combination of cash on hand, as well as committed debt. f Hyder Hospice House an inpatient hospice provider was acquired by Amedisys. Paragon Ventures was the exclusive advisor to Hyder Hospice House in the transaction. Covidien (Mansfield, MA) signed a definitive agreement to acquire BARRX Medical Inc (Sunnyvale, CA), which develops endoscopic treatment solutions for Barrett’s esophagus and other gastroenterological diseases such as esophageal squamous cell neoplasia, bleeding associated with radiation proctopathy, and bleeding associated with gastric antral vascular ectasia. Covidien will acquire all of the outstanding capital stock of BARRX, a private company, for approximately $325 million, with additional future earn out payments possible upon achievement of company milestones Drive Medical has acquired ActiveCare Medical Inc., a manufacturer and distributor of power wheelchairs and mobility scooters, according to an Oct. 28 announcement. Drive Medical also recently acquired Inovo/CHAD Therapeutics, a leading manufacturer of oxygen conserving devices, regulators and other respiratory products. ActiveCare has principal operations in South Carolina, and its broad category of power products include the Medalist, a rear-wheel-drive power wheelchair; the Prowler, a large heavy-duty capacity power scooter; the Cobalt X23, a lightweight, easily transportable power chair; and the Spitfire 1420 EX, a portable scooter. On Oct. 11, Drive announced that it had acquired Inovo/CHAD Therapeutics of Naples, Fla., a sign that the Port Washington, N.Y., company was making a significant expansion into the respiratory market. Gilead Sciences Inc. agreed to acquire Pharmasset Inc. for nearly $11 billion, placing a big bet on the growing market for new treatments for hepatitis C infections. Gilead, which is known mainly for its blockbuster treatments for the AIDS virus, agreed to pay $137 per Pharmasset share, a nearly 89% premium to Pharmasset’s closing price Friday and an impressive return for a stock that traded below $10 as recently as January 2010. Pharmasset shares soared 85% at $134.17 in early trading Monday, while Gilead’s shares dropped 11% at $35.67. The pricey deal underscores the fierce competition among buyers and investors for high quality growig healthcare businesses. Jordan Health Services and CIMA Hospice Announce Combination Jordan, a Texas provider of home health services, will combine with CIMA which provides hospice services in four locations in Southwest Texas. Palladium Equity Partners and F&M Bank and Trust Company will finance the transaction Vista Equity Partners (San Francisco, CA) completed its acquisition of Sage Group PLC’s healthcare business, Sage Healthcare Division (Tampa, FL). The new company will be called Vitera Healthcare Solutions (Vitera) and will continue to serve the ambulatory market with its current line of electronic health records (EHR), practice management and revenue cycle management products. As part of the closing deal, Betty Otter-Nickerson, former president of Sage Healthcare Division, will transition her leadership responsibilities to the newly appointed CEO of Vitera, Matthew Hawkins. Otter-Nickerson will remain until the end of the year. HMS Holdings Corp. last week announced an agreement to acquire privately held HealthDataInsights, Inc. for about $400 million. The transaction is expected to close by Dec. 31, subject to regulatory approvals. HDI is the exclusive Medicare Recovery Audit Contractor (RAC) in 17 states and three U.S. territories in CMS Region D, the Western U.S., covering about 22 percent of the nation’s Medicare claims. Zimmer Holdings Inc (Warsaw, IN) acquired ExtraOrtho Inc (Memphis, TN), including its external fixation line, XtraFix External Fixation System. The acquisition further enhances Zimmer’s position in the growing external bone fixation market. Details of the deal were not disclosed. Sentinel Capital Partners adds WellSpring Pharmaceutical Corporation, a North American manufacturer and marketer of specialty prescription and over-the-counter pharmaceuticals, to its collection. Sentinel teamed up with Ancor Capital Partners, an independent sponsor with extensive healthcare expertise, on the deal. Terms of the deal were undisclosed. Siemens Healthcare (Malvern, PA) entered into a definitive agreement to acquire all issued and outstanding equity of MobileMD Inc (Yardley, PA), a provider of health information exchange (HIE) solutions. The transaction is not subject to any regulatory clearances and is expected to close promptly. MobileMD’s cloud-deployed HIE service liberates patient information across a community of providers, regardless of geographic, organizational, or health IT system boundaries. The HIE solution is in use by more than 110 hospitals and more than 2,000 physician practices. Terms of the deal were not disclosed. PerkinElmer Inc (Waltham, MA) completed its acquisition of Caliper Life Sciences Inc (Hopkinton, MA) for approximately $600 million in cash. Kevin Hrusovsky, CEO of Caliper Life Sciences, was named president of life sciences and technology at PerkinElmer, the business unit that houses the company’s existing research business and Caliper Life Sciences operations RegionalCare Hospital Partners (Brentwood, TN) merged with Essent Healthcare (Nashville, TN) in November 2011. The merged organization, operating under the name RegionalCare Hospital Partners, owns and operates seven hospitals in six states, including Texas, Alabama, Connecticut, Ohio, Iowa and Pennsylvania. Terms of the deal were not disclosed. As part of the agreement, RegionalCare will continue the campus consolidation plans underway in Paris, Tennessee; continue to recruit and retain physicians; and make needed capital investments at the individual hospitals. It also intends to retain all Essent employees and management teams. Martin Rash will continue to serve as RegionalCare’s Chairman and CEO. RegionalCare is a Warburg Pincus LLC (New York, NY) company. Essent Healthcare is a company of Vestar Capital Partners (New York, NY) and Cressey & Company (Chicago, IL). HMS Holdings Corp., a New York-based benefits coordinator for payers, has signed a definitive agreement to acquire privately held HealthDataInsights, Las Vegas, a recovery audit contractor technology firm, for approximately $400 million. The deal calls for HDI to become a wholly owned subsidiary of HMS Holdings Corp. and for HDI founder, President and CEO Andrea Benko to continue in her current roles. HDI employs about a total of 400 people at the company’s headquarters in Las Vegas and in facilities in California and Florida. The deal will consist of $384 million in cash paid at closing and approximately $16 million in the assumption of unvested stock options, according to a news release. The assumed options will be adjusted as to exercise price and number of shares to convert them into options for HMS stock. HMS also plans to establish a $100 million bank revolving credit facility in connection with the deal. Using HMS’ revenue recognition methodology, HDI is projected to add about $85 million of revenue to HMS in 2012, according to the release. Ethicon Endo-Surgery Inc (Cincinnati, OH) completed its acquisition of privately-held SterilMed Inc (Maple Grove, MN), which offers products and services including medical device reprocessing, equipment repair, and pre-owned equipment sales that help healthcare providers lower their medical device and equipment costs, while reducing the amount of environmental waste they generate. Terms of the deal were not disclosed. SterilMed will continue to operate as a standalone company, and announced the appointment of Mike Gustafson as president to succeed Brian Sullivan, who intends to retire from the company following a transition period. Shareholders in investment firm Blackstone Capital Partners (New York, NY) voted to finalize the company’s $3 billion purchase of Emdeon (Nashville, TN), a healthcare payment and revenue cycle management and clinical information exchange solutions provider. Blackstone is acquiring a controlling interest in Emdeon, and Hellman & Friedman will maintain a significant equity interest in Emdeon. MMS – A Medical Supply Company (Earth City, MO) completed its acquisition of Richmark Medical Supply Company (West Chicago, IL). The company will now operate under Richmark Medical, a division of Midwest Medical Supply.Terms of the deal were not disclosed. The deal will allow MMS to strengthen its presence and expand its service capabilities in the Greater Chicago market. Waud Capital Partners (“WCP”), a Chicago based middle-market private equity firm, today announced that Acadia Healthcare Company, Inc. (“Acadia” or the “Company”), majority owned by WCP, has completed its merger with PHC, Inc., d/b/a Pioneer Behavioral Health (AMEX:PHC). As a result of the transaction, Acadia is the country’s leading publicly traded pure-play provider of inpatient behavioral health care services, based upon licensed beds. The Company operates 34 facilities, with approximately 1,950 licensed beds in 18 states, which would have produced annual revenues of more than $325 million on a pro forma basis for the twelve months ending June 30, 2011. Skilled Healthcare Group, Inc. (NYSE: SKH) today announced the acquisition of Cornerstone Hospice, a leading hospice company serving the Phoenix, Arizona and Riverside, California markets. Cornerstone Hospice’s two agencies, which are located in Phoenix and in Colton, California, generally serve areas of their metropolitan markets that are not served by the Company’s existing hospice businesses. The Company expects the acquisition to be slightly accretive in 2011. Kindred Healthcare, Inc. announced that its subsidiary has acquired the assets of Synergy Home Health Care, Inc. (“Synergy”), a provider of home health services. The financial terms of the transaction were not disclosed. The Company used its operating cash flows and proceeds from its revolving credit facility to finance the transaction. Kindred did not assume any liabilities or debt of Synergy in the transaction. Synergy is a home health company serving the greater Boston, Massachusetts market, with two locations in Marlborough and Weymouth, Massachusetts, that currently generate annualized revenues of approximately $5 million. Kindred currently operates 25 nursing and rehabilitation centers and five long-term acute care hospitals within Synergy’s service areas. Kindred’s Peoplefirst HomeCare and Hospice currently provides hospice services in Massachusetts as well as home health and hospice services in Arizona, California, Colorado, Indiana, Nevada, Ohio and Utah. Aprima Medical Software, a Carrollton, Texas-based provider of practice management and electronic health-record software, announced that it has acquired Health Care Strategies, a Richardson, Texas-based revenue-cycle management services provider for physicians. No terms were disclosed. Both companies are in suburbs of Dallas. According to the Health Care Strategies’ website, the companies entered into a formal business alliance in August 2006. Aprima was founded in 1998 as iMedica Corp., but changed its name in 2009. The state of New Jersey approved the sale of Hoboken University Medical Center (Hoboken, NJ) for $10.2 million to HUMC Holdco (Hoboken, NJ), a for-profit company that also operates Bayonne Medical Center (Bayonne, NJ). Under the terms of the sale, Hoboken Municipal Hospital Authority (Hoboken, NJ), the agency that controls the hospital, will pay off the hospital’s debt to creditors, who are owed more than $34 million, and invest $20 million in improvements. The interest on the bond, $11 million, will be covered by an earmark in the state budget. Cigna agreed on Monday to buy HealthSpring for about $3.7 billion in cash, in a bid to add Medicare and senior care coverage. Under the terms of the deal, Cigna will pay $55 a share, a 37 percent premium to HealthSpring’s Friday closing price. The deal is the latest seeking to take advantage of an expected growth in Medicare and insurance of seniors, an area where Cigna does not have a significant presence. HCA Holdings Inc (Nashville, TN) completed its agreement to buy out Colorado Health Foundation’s (Denver, CO) 40 percent interest in HealthONE (Denver, CO) for $1.45 billion. HealthONE, which is the largest healthcare system in the metro Denver area with 8,700 employees and 3,000 affiliated physicians, has seven hospitals and 13 ambulatory surgery centers as well as more than 30 occupational medicine/rehabilitation, specialty, and outpatient diagnostic imaging clinics; and AirLife Denver, which provides critical care air and ground transportation for an eight-state region. HCA will establish an independent advisory board and continue indigent care and graduate medical education programs in accordance with the original terms of the deal. Neoprobe Corp (Dublin, OH) completed the sale of its handheld gamma radiation detector business to Devicor Medical Products Inc (Cincinnati, OH) for $30 million plus $20 million in pledged royalties. The product was Neoprobe’s chief source of revenue. The sale allows Neoprobe to focus on the development of radioactive diagnostic drugs. GE Healthcare (Waukesha, WI) signed an agreement to acquire PAA Laboratories (Pasching, Austria), a developer and supplier of cell culture media for biomedical research and the biopharmaceutical and vaccine manufacturing industry. The acquisition will allow GE Healthcare to expand its offering of products and services for cell biology research and for the discovery and manufacture of biopharmaceuticals including recombinant proteins, antibodies and vaccines. Terms of the agreement, which is expected to close by Q4 2011, were not disclosed. BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of its acquisition of Carmel Pharma, AB, a Swedish company that manufactures the PhaSeal(r) System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials. The acquisition expands the scope of BD’s healthcare worker safety emphasis to include hazardous drug exposure reduction. GE Healthcare (Waukesha, WI) signed an agreement to acquire PAA Laboratories (Pasching, Austria), a developer and supplier of cell culture media for biomedical research and the biopharmaceutical and vaccine manufacturing industry. The acquisition will allow GE Healthcare to expand its offering of products and services for cell biology research and for the discovery and manufacture of biopharmaceuticals including recombinant proteins, antibodies and vaccines. Terms of the agreement, which is expected to close by Q4 2011, were not disclosed. KPS Capital Partners has agreed to sell Attends Healthcare to the NYSE-listed Domtar Corporation for $315 million in cash. The deal is expected to close within the third quarter. It was reported that KPS made a 15x return on the deal and an initial return rate of 120 percent. The firm initially created the business in January 2007 using capital commitments from its KPS II fund. During that time Attends acquired PaperPak Products from Attends Healthcare Investments Ltd. While under the ownership of KPS, Attends managed to complete two recapitalizations. March of last year it raked in $98 million to refinance its outstanding debt and distributed $60 million to its stockholders. The second time around, Attends pulled in $133 million. It used the recap to refinance outstanding debt and its stockholders received $35 million. Attends, which has close to 300 employees, produces and distributes a line of adult incontinence products which are marketed throughout North America. Its primary brand name, Attends, is available through the non-retail sectors within the acute care, long-term care and the home healthcare industry. Brucker Corporation (Billerica, MA), a global manufacturer of scientific instruments, closed its acquisition of Center for Tribology Inc (CETR) (Campbell, CA), a provider of testing and consulting services to high-tech companies, for $13 million in cash as an initial purchase price. The deal also offers the potential for additional earn-out payments of up to $4 million in cash, depending on growth and profitability of the CETR-business within Bruker in 2012 and 2013. CETR is now part of the Bruker Nano Surfaces division, joining the current AFM (atomic force microscope) and SOM (stylus and optical metrology) businesses. Dr Norm Gitis, founder and CEO of CETR, will serve as VP and general manager of the new Bruker Tribology & Mechanical Testing (TMT) business. SpecialtyCare, a Nashville-based provider of clinical services to surgeons and hospitals, has acquired Surgical Monitoring Associates, Inc. (SMA) and Remote Neuromonitoring Physicians (RNP), Springfield, Pa. SMA has provided intraoperative neurophysiological monitoring since 1986. The purchase of SMA and RNP, both Philadelphia-based companies, was completed October 1, 2011, just one month after SpecialtyCare purchased Advanced Diagnostics Inc., a longstanding Northern California neuromonitoring group. AeroScout® (San Mateo, CA), a provider of Unified Asset Visibility solutions for the healthcare industry, acquired Sentient Health (Redwood City, CA), a provider of software and services to hospitals for optimizing inventory management of consumable medical supplies. According to a report by the standards organization GS1 UK, the top two technologies identified by nurses to help them improve efficiency and patient safety were: 1.) technologies that provide real-time views of stock levels (63 percent); and 2.) technologies for tracking the location of equipment electronically (56 percent). AeroScout, through its acquisition of Sentient Health, is a leader in both of these areas with AeroScout’s Asset Tracking and Management solution and Sentient Health’s MedTrac solution for supply chain visibility. Hospitals use Sentient Health’s MedTrac software to automate supply chain management of consumable medical supplies, such as stents, syringes and gloves, which is a complex and time-consuming manual process. MedTrac enables healthcare providers to manage their inventories and automate procurement, increasing efficiency while reducing operating costs and saving staff time. Terms of the acquisition were not disclosed. NationsHealth acquired Care 1st Medical Solutions. The five-year-old Care 1st offered mail-order diabetes testing supplies to about 13,000 Medicare beneficiaries. Care 1st CEO Mike Eberly confirmed the deal and blamed competitive bidding. NationsHealth, which won several mail-order contracts in Round 1, billed Medicare more than $13 million for test strips. Peninsula Hospital in southeast Queens, NYC announced that it had reached a deal for Revival Home Health Care to acquire the financially ailing hospital center. Todd Miller, chief restructuring officer for Revival, said the group was “very proud to be able to step in and save Peninsula Hospital Center for Rockaway community.” Revival is a for profit agency that largely serves New York’s Orthodox Jewish community. Pending final NYS Department of health approval, Peninsula’s Board of Directors have agreed to allow Revival to take over the day to day operations effective immediately. Peninsula Hospital Center will be removed from ambulance diversion as of Friday. Area ambulances had been diverted to other hospitals since August 22. State Health officials had ordered Peninsula to stop taking new patients and prepare a transfer-or-discharge plan for its patients after its parent network, Medisys Health, withdrew support for the struggling 200 bed facility. Greater Regional Medical Center’s board of trustees voted unanimously to merge with Iowa Home Health and Hospice effective Jan. 1, 2012. GRMC executives said, over the past two to three years, they’ve explored home health care and hospice partners in order to better meet changing regulatory demands and reimbursement challenges. And, after careful review, GRMC approved the merger largely because Iowa Health shares GRMC vision and values to place full emphasis on patient-centered care. Kindred Healthcare agreed to acquire home health company, Professional HealthCare for $51 million. The acquisition will add 27 more home care, hospice and private duty locations to Kindred’s service area. Getinge Group (STO:GETIB) and its subsidiary, Maquet Cardiovascular, a global provider of cardiovascular technologies, announced that it has signed a definitive agreement to acquire Atrium Medical Corporation for $680 million. Atrium provides medical device technologies for interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. Atrium will operate as an independent, self-contained business unit of MAQUET Cardiovascular and will be led by current Atrium president, Trevor Carlton. The transaction is expected to close in the fourth quarter of 2011, subject to U.S. Federal Trade Commission (FTC) approval. Atrium’s vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. Founded in since 1838, MAQUET is a global leader in medical systems that advance surgical interventions, cardiovascular procedures and critical care. MAQUET develops and designs innovative products and therapeutic applications for the operating room, hybrid OR/cath lab, intensive care unit and patient transport within acute care hospitals, improving outcomes and quality of life for patients. GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. GETINGE GROUP operates under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control within healthcare and contamination prevention within life sciences. Brightree, a provider of a suite of SaaS solutions that automates and organizes multiple critical business functions for healthcare providers and practitioners was recapitalized by Battery Ventures. The Company’s management team had grown the Company quickly since joining and investing in the Company several years ago. The original founders were ready for a liquidity event while the management team wanted to explore partnerships for continued growth. Brightree was recapitalized with equity financing from Battery Ventures, a nationally-recognized private equity firm that brought capital and expertise in the software industry. C&B Capital also participated in the transaction. American Hospice, a portfolio company of The Riverside Company, recently announced its acquisition of the Conroe and Livingston, Texas locations of Hospice Care of the Southwest, a leading provider of hospice services in the Houston suburbs. Clearview Capital announced that it has acquired Child Health Holdings, Inc. from Harbert Private Equity. Headquartered in Tampa, FL Child Health Holdings, d.b.a. Pediatric Health Choice, is the premier provider of alternative-site health care services for medically complex, technology-dependent and behaviorally challenged children. The transaction closed on September 2nd. CI Capital Partners has acquired the Arlington, Illinois-based health and wellness solutions provider, Interactive Health Solutions (IHS). Although terms of the deal for IHS were undisclosed the firm typically spends between $25 million to $100 million in equity per transaction. IHS, which was established in 1991, works with more than 1,000 fully-insured and self-insured companies. The company develops and offers wellness programs to employer groups that help individuals take responsibility for their health. It offers biometric screening, telephonic health coaching and health compliance program management. CI Capital acquired the company from its founder and handful of owners, including Jim Banks who will remain as a member on the board. Joe O’Brien will continue as the company’s CEO. Kohlberg & Co. LLC-backed Phillips Plastics Corp. is expanding the medical device end of its business. The Hudson, Wisconsin-based portfolio company announced Friday that it has agreed to acquire Medisize Corp. from Swedish private equity conglomerate Ratos AB. Terms of the transaction were not disclosed. Phillips, which was acquired by Mount Kisco, N.Y.-based Kohlberg on Dec. 10, is known for manufacturing injection molding components for plastic and metal devices used within the consumer, medical, defense and automotive industries. The company has strategic partnerships with Eastek International – forming Chinese tool company WahTsun Far East Ltd. – and Pro-Tek Medical Ltd. This deal is expected to significantly expand Phillips’ manufacturing capabilities in Europe thanks to Medisize’s presence in Finland – where it’s headquartered – and its operations in Ireland, The Netherlands, Switzerland and the Czech Republic. Family Equity Partners and Housatonic Partners to complete a deal with HealthWyse, a leading provider of clinical and financial software to home health, hospice and private duty agencies. Founded in 1998, HealthWyse is a leading provider of clinical and financial software solutions for home care, hospice and private duty agencies. The company’s fully integrated services and software offerings include a Point of Care (with electronic health record), Clinical Management and Billing solution customized to meet the needs of various agencies. CareSouth Homecare Professionals purchases Florida Palliative Home Care, continuing its growth through acquisition strategy. Metropolitan Health to Acquire Continucare for $416 Million This deal will expand Metropolitan Health’s services to Medicaid and Medicare patients in Florida. PerkinElmer Inc (Waltham, MA) plans to acquire Caliper Life Sciences Inc (Hopkinton, MA), a manufacturer of molecular imaging and detection technologies for life sciences research and diagnostics, for $600 million. PerkinElmer plans to pay cash, and the deal is expected to close in Q4 2011. Caliper CEO Kevin Hrusovsky is expected to join PerkinElmer’s senior leadership team, though a position wasn’t specified. AmerisourceBergen (Chesterbrook, PA) paid $250 million to acquire TheraCom Corp (Bethesda, MD), a subsidiary of CVS Caremark Corp (Woonsocket, RI) that provides consulting, reimbursement services and other support to pharmaceutical and biotechnology drug manufacturers. TheraCom will join Lash Group as part of AmerisourceBergen Consulting Services. TheraCom’s annualized revenues are approximately $700 million, mostly from the specialized distribution component of the integrated reimbursement support services for certain unique prescription products. Sage Group PLC plans to sell its healthcare business, Sage Healthcare Division (Tampa, FL), to private equity firm Visa Equity Partners (Austin, TX) for $320 million in cash. Proceeds of the sale, which is expected to close next month, will be given back to shareholders through a share buy-back program. Sage originally bought the business five years ago for $565 million from Emdeon (Nashville, TN). Sony Corporation (Tokyo, Japan) announced the acquisition of U.S. start-up firm Micronics Inc (Redmond, WA) to begin the launch of research and development operations in the potentially lucrative market for medical equipment. The 30-employee Micronics develops equipment for molecular diagnostics and monitoring. No financial details were disclosed. Aesculap Inc (Center Valley, PA) acquired the assets of Aragon Surgical Inc (Palo Alto, CA), which specializes in advanced radio frequency (RF) electrosurgical instruments for tissue fusion and cutting. The deal includes the Caiman® product line of instruments which, according to the company, are the only RF devices on the market with an articulating jaw-technology. The Caiman advanced energy product line complements Aesculap’s extensive line of endoscopic and open surgical instruments. Terms of the agreement were not disclosed. Ethicon Endo-Surgery Inc (Cincinnati, OH) signed a definitive agreement to acquire privately-held SterilMed Inc (Maple Grove, MN), which offers products and services including medical device reprocessing, equipment repair, and pre-owned equipment sales that help healthcare providers lower their medical device and equipment costs, while reducing the amount of environmental waste they generate. SterilMed will be managed as part of the Ethicon Endo-Surgery franchise, but will continue to operate as a stand-alone company and retain its name. Terms of the agreement were not disclosed. Cahaba Media Group (CMG), headquartered in Birmingham, Alabama, has acquired HomeCare magazine,, and the HomeCare Monday e-newsletter from Penton Media as of September 20, 2011. Terms were not disclosed. Varian Medical Systems, a Palo Alto, Calif.-based medical-device and software manufacturer, has signed an agreement to acquire Calypso Medical Technologies for $10 million. The deal, announced Tuesday, also allows for additional payments based on unit sales of Calypso’s products over the next two-and-a-half years, according to a Varian Medical news release. Seattle-based Calypso is privately owned. It develops products and software that are used for real-time tumor tracking and motion management during radiosurgery and radiotherapy. According to the release, Calypso’s products complement Varian’s motion management technology, which is also used in radiosurgery. Calypso’s operations are expected to be integrated into Varian’s oncology systems business unit but will continue to be based in Seattle. Clinical services provider SpecialtyCare, Nashville, has acquired fellow clinical outsourcing company Active Diagnostics, Fair Oaks, Calif. Terms of the deal were undisclosed in a SpecialtyCare news release. SpecialtyCare, which serves more than 570 hospitals across the U.S. and in Germany, offers surgical and anesthesia support, sterile processing department management and intraoperative neurological monitoring, among other services. In 2010, the company’s client roster grew 56.5%. Active Diagnostics specializes in neuromonitoring and serves 35 hospitals in Northern California and Nevada, according to the release. Earlier this year, SpecialtyCare purchased Advanced Perfusion Care of North Carolina. ImpactRx, a Symphony Technology Group (STG) company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies, in order to combine the highly complementary capabilities of the two companies into a stronger solution offering for customers. The new company will be known as ImpactRx and new ImpactRx President and CEO, Gregory Ellis, will lead the combined company. Financial terms of the transaction were not disclosed. Baird Capital Partners (“BCP”) has completed the sale of BCP IV portfolio company Medical Education Technologies, Inc. (METI) to CAE (NYSE: CAE; TSX: CAE). Total expected proceeds will generate an estimated 2.5x gross return on investment for BCP IV investors. BCP acquired METI in October of 2008. Based in Sarasota, Fla., METI develops simulators and other learning tools that help educate and train doctors, nurses, first responders and military medics by providing a learning platform that allows students and practitioners to practice without harming real patients. Medtronic Inc (Minneapolis, MN) acquired Peak Surgical (Palo Alto, CA) and Salient Surgical Technologies Inc (Portsmouth, NH). The total value of the transaction for Peak Surgical was $120 million and Salient Surgical was $525 million; however, Medtronic previously invested in both and held an ownership stake in the companies. The final transaction value came to approximately $105 million for Peak Surgical and $480 million for Salient Surgical. DaVita Inc. announced Tuesday it’s closed on its purchase of DSI Renal Inc. of Nashville after agreeing to the Federal Trade Commission. Denver-based DaVita Inc. (NYSE: DVA), in February disclosed its plan to purchase DSI Renal for $689 million. But the FTC on Friday said DaVita would have to sell more than two dozen kidney dialysis clinics in order to avoid gaining a monopoly or becoming one of only two providers in 16 markets. DaVita said it will sell 30 clinics — most of which it acquired from DSI Renal — for $91 million. Before the purchase of DSI, DaVita ranked as the second-largest dialysis company with more than 1,600 clinics in 42 states. DSI Renal was No. 5, with 106 clinics in 23 states. DSI Renal has annual revenue of about $360 million. DaVita reported $6.1 billion in revenue last year. AmerisourceBergen Corp. has closed on a $35 million deal to acquire IntrinsiQ, an oncology software company. IntrinsiQ will operate within ION Solutions, AmerisourceBergen’s oncology division, according to an AmerisourceBergen news release. Valley Forge, Pa.-based AmerisourceBergen, a pharmaceutical distributor, consultant and packing company, said the deal would not significantly change its 2011 earnings. IntrinsiQ, based in Burlington, Mass., had treatment data from about 750 oncologists and roughly 20,000 patients in its database as of March, according to the company’s website. KPS Capital Partners has sold its portfolio company Attends Healthcare to Domtar (NYSE: UFS) for $315 million, netting a 15x return on its investment. KPS has owned Attends since 2007 and was legally advised on the sale by Paul Weiss Rifkind Wharton & Garrison. Attends provides incontinence care products and washcloths. Stryker Corporation (Kalamazoo, MI) plans to acquire privately-held Concentric Medical Inc (Mountain View, CA) for $135 million. Concentric Medical is a medical device company focused on the design, development and commercialization of minimally invasive medical devices for use in the neurovasculature. Its sales for the current year are expected to total over $30 million, and the company’s products are sold in the U.S., Europe and Japan. The all-cash deal, scheduled to close early in Q4 2011, is expected to be neutral to Stryker’s 2011 earnings. Summit Partners receives FTC approval to take the home nursing company off the Chicago PE firm’s hands. Boston-based Summit Partners received early termination under the Hart Scott Rodino period to acquire CareCentrix Holdings Inc., according to the Federal Trade Commission. The deal marks a quick flip for buyout firm Water Street Healthcare Partners LLC, which purchased a 69% stake in East Hartford, Conn.-based CareCentrix just three years ago as part of its acquisition of a controlling stake in the ancillary care benefit management business of Gentiva Health Services. Terms of today’s transaction have not been disclosed but Chicago-based Water Street originally spent $147 million in August 2008 on CareCentrix and Summit usually invests up to $500 million in equity and debt for each of its targets. Water Street, which focuses solely on healthcare acquisitions, was spun off from One Equity Partners in 2005, the private equity arm of JPMorgan. It acquired CareCentrix through its second fund, Water Street Healthcare Partners II LP. CareCentrix, which delivers home nursing and home medical equipment to over 10 million individuals, was founded in 1996. Its management team remained on board when it was first picked up by Water Street. It has locations in Phoenix, Tampa, Fla., Albuquerque, N.M. and Overland Park, Kan. Zynex Inc (Littleton, CO), a developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, plans to acquire substantially all of the assets of NeuroDyne Medical Corp (Cambridge, MA). NeuroDyne is manufacturer of medical instruments, sensors, disposable electrodes and software that offer sEMG, EKG, EEG, respiration, skin temp, EDR, EDL, peripheral blood flow, IBI, heart rate, and heart rate variability. Zynex will make the acquisition through its subsidiary, Zynex NeuroDiagnostics Inc. Terms of the agreement were not disclosed. Baxter International has acquired Baxa, which specializes in improving the safety and delivery of oral and IV drugs, generated roughly $150M in 2010. These days, Baxter International Inc. has been making strides to complement its drug and therapy portfolio. Shelling out $380 million in cash for drug delivery company Baxa Corp. underscores this goal. The deal, announced Thursday, follows last month’s announcement that the NYSE-listed company will invest up to $200 million in early-stage companies through its established Baxter Ventures. Even though privately held Baxa doesn’t fall under the category of a start-up, having been around for 36 years , the acquisition serves as another step in Baxter’s quest to diversify itself as well as expand its existing intravenous (IV) business. The Englewood, Col.-based target, which generated roughly $150 million in 2010, specializes in improving the safety and delivery of oral and IV drug preparation. “This planned acquisition builds upon an earlier announcement this year,” a Baxter spokeswoman explained, citing the company’s purchase of Prism Pharmaceuticals Inc., a King of Prussia, Pa.-based company that develops and markets premixed IV bags to hospitals, for $338 million in April. Before that, the Deerfield, Ill.-based medical device maker purchased all of the hemophilia-related assets of Archemix, a privately-held biopharmaceutical company, in November. A month earlier it found itself on the other end of the negotiation table, divesting its U.S. generic injectables business. London-based Hikma Pharmaceuticals plc picked up the segment for approximately $112 million. Baxter expects all accounting and transaction-related expenses tied to the transaction to reduce 2012 earnings by at least 3 cents per share. The acquisition, however, will add to earnings in 2013 and beyond, it said. Its market capitalization at the time of the announcement was about $30.1 billion. Kindred Healthcare Inc (Louisville, KY) signed a definitive agreement to acquire Professional HealthCare (Walnut Creek, CA) for $51 million in cash. Professional is a provider of home health, hospice, private duty nursing services and durable medical equipment. With 27 locations in California, Arizona, Nevada and Utah, Professional generates annualized revenues of approximately $53 million and will have no outstanding long-term debt at closing. Subject to regulatory approvals and other conditions, the transaction is expected to close by the end of Q3 2011. Kindred expects that the transaction will be slightly accretive to earnings in 2012. Mölnlycke Health Care (Gothenburg, Sweden) acquired Rynel Inc (Wiscasset, ME), a manufacturer of specialty absorbent polyurethane foam products. Rynel supplies companies in North America, Europe, Africa and the Far East with products addressing a wide range of foam applications. Terms of the deal were not disclosed. Aprima Medical Software, a Carrollton, Texas-based provider of practice management and electronic health-record software, announced that it has acquired Health Care Strategies a Richardson, Texas-based revenue-cycle management services provider for physicians. No terms were disclosed. Both companies are in suburbs of Dallas. According to the Health Care Strategies’ website, the companies entered into a formal business alliance in August 2006. Aprima was founded in 1998 as iMedica Corp., but changed its name in 2009. Private-equity firm Apax Partners, London, and other investors have reached a deal partially financed by debt to acquire Kinetic Concepts, a publicly traded wound-care and tissue-regeneration company, for $6.3 billion. A consortium comprised of funds advised by Apax Partners (“Apax”), together with controlled affiliates of Canada Pension Plan Investment Board (“CPPIB”) and the Public Sector Pension Investment Board (“PSP Investments”), today announced that it has entered into a definitive agreement to acquire Kinetic Concepts, Inc. (NYSE: KCI) for $68.50 per common share in cash. KCI is a U.S.-based medical device company focused on the design, manufacture, marketing and service of therapies and products for the wound care, tissue regeneration and therapeutic support system markets. The transaction is valued at approximately $6.3 billion, including KCI’s outstanding debt. In 2010, KCI reported revenues of $2.0 billion. The company’s products address a broad range of patient needs and are used by healthcare professionals around the world in a wide range of diverse care settings, such as acute care hospitals, long-term care and skilled nursing facilities, home health agencies and wound care clinics. Buddy Gumina, Partner and co-head of the Apax Healthcare team, commented: “We are highly impressed by the culture of innovation at KCI and are excited to work with a business that produces solutions that dramatically improve the lives of many people around the world. Over the years, we have reviewed multiple investments in the medical devices and products industry, having originally identified it as a key growth sector within our overall healthcare investment practice. Based on this experience, we possess a deep understanding of KCI’s business and the markets in which the company operates. We are delighted to have the opportunity to partner with CPPIB and PSP Investments to support the company’s continued growth.” André Bourbonnais, Senior Vice-President, Private Investments for CPPIB, said, “KCI is the market leader in its businesses with strong growth potential particularly outside of the core U.S. market. KCI’s business is well positioned for growth based on global trends such as demographics, including longevity and an aging population. Together with KCI’s management, Apax and PSP Investments, we look forward to building upon KCI’s leading market shares and positioning the company for continued long-term success.” The transaction is subject to shareholder and regulatory approvals and other customary conditions. It is currently expected that the acquisition will close in the second half of 2011. Lamano Agency has been purchased by Lutheran Family Services of Virginia, a well-respected nonprofit that provides educational and social services, that has long wanted to provide services to adults with intellectual or developmental disabilities. Our day-to-day operations will continue as usual, and we will continue to use The Lamano Agency name. Almost Family entered into a stock purchase agreement with the shareholders of Cambridge Home Health Care Holdings, Inc. (Cambridge) an Ohio based provider of home health services with $38 million in annual revenues. Cambridge operates a total of 38 home health branches with 35 in Ohio and 3 in western Pennsylvania. Cambridge services over 3,000 patients annually. The Company will be acquiring 100% of the outstanding equity interests of Cambridge with a cash-free, debt free balance sheet for an all-cash purchase price of $32.5 million. The transaction is expected to close by August 6, 2011. In its audited financial statements for the year ended December 31, 2010 Cambridge reported $38.2 million in revenues of which $33.7 million would be classified in our Personal Care segment and $4.5 million would be classified in our Visiting Nurse segment. Net income was $4.3 million after interest expense and related party management fees of $1.1 million. Cambridge is a subchapter S Corporation for income tax purposes and thus had no income tax provision. The Company expects to eventually achieve approximately $1.0 million to $1.5 million in combination synergies. However, the Company expects also to incur certain costs of integration of systems and processes in a range of $600,000 to $800,000 over its planned transition time frame of 6 to 9 months. Finally, reductions in Ohio Medicaid and Passport reimbursement rates going into effect on July 1, 2011 and October 1, 2011 are expected to reduce annual revenue and pre-tax income by approximately $620,000. Senior Care Inc., a national senior housing provider, acquired a 100-bed assisted living facility in Florence, KY, from Louisville-based Ethos Assisted Living for $15.5 million, or about $150,000 per bed. The purchase and debt financing was handled by an affiliate of Chicago-based Ventas Inc. The facility recently opened in January and provides dementia and memory-care services. The facility is at 212 Main St. in Florence. Senior Care also purchased The Ethos of Mount Washington, a 68-bed assisted living facility, for an additional $7.7 million. These two facilities are Senior Care’s first assisted-living communities in Kentucky. Staffing company On Assignment Inc. said Monday that it has acquired physician staffing firm HealthCare Partners Inc. for $15 million. The transaction terms include a potential payout of up to an additional $3.7 million. On Assignment used cash and debt borrowed against its senior revolving credit line to fund the acquisition. It anticipates it will achieve an after-tax savings of about $450,000 a year over the next 15 years by classifying the purchase as an asset sale under the federal tax code. On Assignment also expects the transaction to immediately contribute to earnings. Atlanta-based HealthCare Partners has 41 employees and places physicians in 14 specialties across 24 states. Company founders Ruddy and Rhonda Polhill will continue to run the company under its new ownership. Merge Healthcare (Chicago, IL) completed its acquisition of Ophthalmic Imaging Systems (OIS) (Sacramento, CA), a provider of digital imaging and informatics solutions for ophthalmology and other medical specialties. Merge Healthcare will add OIS’ ophthalmic imaging and informatics solutions, including a single platform electronic health record (EHR) and practice management system, a digital imaging management solution and a modular imaging device that can capture images of both the anterior and posterior segments of the eye, to its portfolio. Terms of the deal were not disclosed. Emdeon (Nashville, TN), a healthcare payment and revenue cycle management and clinical information exchange solutions provider, will merge with investment firm Blackstone Capital Partners (New York, NY) in a $3 billion deal that gives a controlling interest to Blackstone. Emdeon will become a private company, and Hellman & Friedman will maintain a significant minority equity interest in Emdeon. The transaction is subject to customary closing conditions, including approval by Emdeon’s stockholders and clearance under the Hart-Scott-Rodino Act, and is expected to be completed in the second half of 2011. Accelrys Inc (NasdaqGS: ACCL) has acquired Contur Software AB for $13.1 million. The acquisition, which closed on May 23, 2011 includes $10.6 million in cash paid at closing, $2 million in cash kept in escrow to secure specific warranties which will be released in $1 million installments subject to one and two year lock up periods, plus two earnouts of $250,000 each contingent on meeting two tiers of performance milestones in the next 24 months. All members of the Contur Management team will be retained. The acquisition is not expected to have an impact on Accelrys’ GAAP and non-GAAP revenue, operating profit, or EPS for FY2011. Increasing global competition in technology focused industries including chemicals, pharmaceuticals, biotechnology, agriculture, consumer and industrial products, energy, and defense has made investment in the efficiency of R&D and IT processes an exigent priority. Advanced technology research, traditionally led and dominated by North American firms, is getting highly spirited competition from emergent players in Great Britain, Australia, India, Israel, Singapore, South Korea, Germany, as well as developing economies with increasingly robust capital infrastructure. International markets for advanced technology products are swiftly increasing, thus companies in this space are addressing the need to rapidly and cost-effectively bring their products to market through cross-border M&A strategies. Sanofi (Paris, France) announced the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc (Mississauga, Ontario, Canada) for a total cash consideration of $425 million. Dermik’s portfolio includes therapeutic and aesthetic dermatology brands such as BenzaClin® for the treatment of acne, Carac® for the treatment of keratoses and Sculptra®, a facial injectable for the correction of facial wrinkles and folds. The transaction includes Dermik assets, which consist of an aesthetic and therapeutic business in the United States and Canada, as well as an aesthetic business around the world with sales of $206 million in 2010. Also included in the scope is Sanofi’s Laval, Canada site, which includes Dermik’s manufacturing facility. Sanofi’s Canadian affiliate, sanofi-aventis Canada, will maintain its operations in greater Montreal. Health Management Associates (HMA) (Naples, FL) signed a definitive agreement to acquire Mercy Health Partners Knoxville (Knoxville, TN) from Catholic Health Partners (Cincinnati, OH) for $525 million plus certain adjustments for working capital, and the assumption of certain long-term lease liabilities. Under the agreement, HMA will acquire or lease all seven of Mercy’s hospitals, which include a total of 1,323 licensed beds and substantially all of Mercy’s ancillary health care operations. The hospitals included in the transaction are 401-bed Mercy Medical Center Saint Mary’s (formerly Saint Mary’s Medical Center) (Knoxville, TN); 101-bed Mercy Medical Center West (formerly Baptist Hospital West) (Knoxville, TN); 108-bed Mercy Medical Center North (formerly Saint Mary’s Medical Center North) (Powell, TN); 58-bed Saint Mary’s Jefferson Memorial Hospital (Jefferson City, TN); 74-bed Baptist Hospital of Cocke County (Newport, TN); 66-bed Saint Mary’s Medical Center Of Campbell County (LaFollette, TN); and 25-bed Saint Mary’s Medical Center of Scott County (Oneida, TN). HMA will also acquire the former Riverside Hospital (Nashville, TN), which is licensed to operate 293 beds. The proposed acquisition is subject to review and approval by appropriate authorities, including the Vatican, as well as other conditions customary to closing. This transaction is slated to close by October 1, 2011. Provena Health (Mokena, IL) and Resurrection Health Care Corporation (Chicago, IL) reached a definitive agreement to merge. The deal will create the largest Catholic system in Illinois with 12 acute-care hospitals. In 2010, Resurrection reported $1.7 billion in patient revenue and a total loss of $8.7 million. For the same period, Provena reported net patient and resident service revenue of $1.22 billion and net income of $40.5 million. A CON has been filed with the Illinois Health Facilities and Services Review Board. The deal also awaits state regulatory approval. Palladium Equity Partners, LLC, a private investment firm based in New York focused on investments in the U.S. Hispanic marketplace, announced today that one of its affiliates has acquired Jordan Healthcare Holdings, Inc. (“Jordan” or the “Company”). Terms were not disclosed. Founded in 1975, Jordan is one of the largest providers of home healthcare in Texas. Jordan offers home health services to pediatric and adult patients, including personal care, home management and skilled nursing, to Medicaid and/or Medicare eligible patients throughout the state. Roy Serpa, CEO of Jordan Health Services, said, “Over the past 35 years, our Company has grown from a family-run, Medicaid-focused operation into one of the leading professionally-managed diversified home healthcare providers in the attractive Texas market. With this transaction, we will be positioned to pursue growth initiatives, including regional expansion and an increased focus on more skilled healthcare.” David Perez, Managing Director of Palladium Equity Partners, LLC said, “Jordan is well known throughout Texas as one of the premier regional providers of home healthcare services. The Company has a strong management team who over the last five years has built a robust operating platform and has successfully executed on its growth strategy. We look forward to partnering with management to pursue additional opportunities.” Metropolitan Health Networks, Inc. (NYSE AMEX: MDF), (“Metropolitan”) and Continucare Corporation (NYSE: CNU), (“Continucare”) announced jointly today that they have entered into a definitive merger agreement whereby Metropolitan will acquire Continucare in a cash and stock transaction valued at approximately $416 million at the time of announcement. The transaction will create a company that provides care to over 68,000 Medicare Advantage and Medicaid customers. The combined company will own 31 primary care medical practices, utilize a network of more than 250 contracted, independent, primary care practices, and will operate in 18 Florida counties, including the Daytona, Miami, Ft. Lauderdale, West Palm Beach, and Tampa metropolitan areas. Under the terms of the merger agreement, each share of Continucare common stock will receive $6.25 per share in cash, and 0.0414 of a share of Metropolitan common stock, which, based upon the share price at the time of announcement, is equal to approximately $0.20. The exact value of the consideration per share will depend on Metropolitan’s share price at closing. Metropolitan expects to issue approximately 2.7 million shares in connection with the pending transaction. To fund the cash component of the purchase price, Metropolitan plans to use some of its and Continucare’s cash and investments, which combined totaled $93 million at March 31, 2011, and has secured a fully underwritten financing commitment from one of the leading health care lenders, GE Capital, Healthcare Financial Services and its affiliates, to arrange approximately $355 million in new credit facilities. In connection with the financing, GE Capital Markets will serve as Sole Book Runner and Sole Lead Arranger for the debt financing. The combination of Metropolitan and Continucare will create a company with approximately $660 million in annual revenue, based upon their respective results for the twelve months ended March 31, 2011, and over $90 million in earnings before interest, taxes, depreciation and amortization (EBITDA) for the same period. Metropolitan projects annual cost savings principally from the elimination of public company-related expenses as well as the elimination of certain executive level positions, and that the transaction will be accretive in 2012. Oak Hill Capital Partners announced today that following the closing of their acquisition of AccentCare, Inc. (“AccentCare”), a premier provider of home healthcare services, including nursing and attendant care services, they intend to combine it with Guardian Home Care Holdings, Inc. (“Guardian”), a leading homecare and hospice service provider in the Tennessee, Georgia and Texas markets. The terms of the transaction were not disclosed. The combination of AccentCare and Guardian creates one of the largest operators in the industry, with an expanded geographical footprint and highly diversified service offerings. The new company will operate over 130 branches across 10 states, serving more than 30,000 patients. Ansell Limited (Red Bank,NJ) acquired Sandel Medical Industries LLC (Chatsworth, CA), a developer of staff and patient safety disposable products, for $13.5 million. Ansell will continue the Sandel business under the Ansell Sandel Medical Solutions LLC name. Sandel offers products in the following six product categories: sharps safety, ergonomic safety, medication handling and specimen handling, safety kits and safety products/correct site markers for patients. The acquisition is expected to be earnings per share neutral in FY 2012 and accretive from FY 2013 onwards. Standard Register (Dayton, OH) completed its acquisition of Dialog Medical (Atlanta, GA), a medical documentation company. Standard Register now has a 100 percent ownership interest in Dialog Medical, which will be operated as a wholly-owned subsidiary, reporting through Standard Register Healthcare, a business unit of Standard Register. Terms of the deal were not disclosed. IPC the Hospitalist Co. has acquired Coast to Coast Physicians Alliance of Orlando, Fla., for an undisclosed sum. With the deal, the North Hollywood, Calif.-based hospitalist physician group practice will add about 26,000 patient visits annually. Express Scripts (Maryland Heights, MO) plans to acquire Medco Health Solutions Inc (Franklin Lakes, NJ) for $29.1 billion. Express Scripts will pay $28.80 in cash and .81 of its own shares for each Medco share. The deal will make Express Scripts the biggest pharmacy benefits manager in the country. After the deal closes, Express Scripts will own 59 percent of the combined company. George Paz, Express Scripts’ chairman and CEO, will continue to hold those titles. The new company’s board will be expanded to include two current Medco independent directors. The merger is expected to close in the first half of 2012, pending regulatory and shareholder approval. Pfizer Inc (New York, NY) entered into a definitive agreement to acquire Icagen Inc (Research Triangle Park, NC), a company focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. Pfizer, which currently owns approximately 11 percent of Icagen’s fully diluted shares, will acquire the remaining 8.3 million shares at a price of $6.00 per share. The aggregate transaction value, including the value of the shares currently owned by Pfizer, is approximately $56 million. In 2007, Pfizer and Icagen entered into a collaboration for the discovery, development and commercialization of compounds that modify three specific sodium ion channels as new potential treatments for pain and related disorders. The deal is expected to close by the end of 2011. Ecolab Inc (St. Paul, MN) plans to acquire Nalco Holding Co (Naperville, IL), a chemical company specializing in water treatment and pollution control, in a deal worth $8 billion. Ecolab will pay $38.80 per share, or about $5.4 billion. The remainder of the deal’s value is assumed debt. JLL Partners has sold PharmaNet Development Group to Thomas H. Lee Partners-backed inVentiv Health. PharmaNet had been a JLL portfolio company since 2009. Debt financing for the transaction was provided by BofA Merrill Lynch, Citi and Jefferies Finance. PharmaNet provides drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, while inVentiv provides clinical, commercial and consulting services to the healthcare industry. Bound Tree Medical (Dublin, OH) acquired Alliance Medical Inc (Jefferson City, MO), a specialty distributor of emergency medical services (EMS) products, supplies, equipment and clothing that serves customers in more than 30 states. The acquisition advances Bound Tree Medical’s initiative to provide leading-edge equipment, supplies, pharmaceuticals, and value-added services. Terms of the deal were not disclosed. Thermo Fisher Scientific Inc (Waltham, MA) acquired Magellan Biosciences’ (Chelmsford, MA) microbiology business, TREK Diagnostic Systems. The sale will enable Magellan to focus all its resources on its LeadCare® and Dynex® businesses, both of which have been experiencing strong growth. Terms of the deal were not disclosed. Nuance Communications acquired Webmedx, an Atlanta-based transcription services provider for hospitals and clinics, to strengthen its transcription services offerings. A spokesperson for Burlington, Mass.-based Nuance, a provider of speech recognition and transcription services, said financial terms of the deal would not be disclosed. The deal closed June 20. Thoratec Corp (Pleasanton, CA) acquired the medical business of Levitronix LLC (Waltham, MA) for an upfront cash payment of $110 million and potential future cash earnout payments of up to $40 million. Since 2006, Thoratec has provided distribution and clinical support in the U.S. for the CentriMag® Acute Circulatory Support System, Levitronix’s flagship product, under an agreement that was scheduled to expire at the end of 2011. Levitronix and Thoratec also collaborated on the development of the fully magnetically levitated motor technology employed in the HeartMate® III left ventricular assist system, which is currently in preclinical testing. To learn more, visit Symmetry Medical Inc (Warsaw, IN), a provider of medical device solutions including orthopedic implants, surgical instruments, signed a definitive agreement to acquire Olsen Medical (Louisville, KY), which designs, develops and manufactures electrosurgical instruments and accessories. The all cash transaction has certain pre-closing conditions that must be satisfied, and Symmetry anticipates closing the acquisition by August 15, 2011. The transaction will be neutral to the company’s 2011 financial results, excluding acquisition and integration-related charges, and will likely be accretive to the company

Neoprobe Frequently Asked Questions (FAQ)

  • When was Neoprobe founded?

    Neoprobe was founded in 1983.

  • Where is Neoprobe's headquarters?

    Neoprobe's headquarters is located at 425 Metro Place North, Dublin.

  • What is Neoprobe's latest funding round?

    Neoprobe's latest funding round is Unattributed VC.

  • How much did Neoprobe raise?

    Neoprobe raised a total of $2.8M.

  • Who are the investors of Neoprobe?

    Investors of Neoprobe include Alpha Capital Partners, Sands Brothers Venture Capital, WEC Partners, Bristol Capital Advisors, Bridges and PIPES and 4 more.

  • Who are Neoprobe's competitors?

    Competitors of Neoprobe include Vessix Vascular.

Compare Neoprobe to Competitors

Vessix Vascular

Vessix Vascular, formerly known as Minnow Medical, is a privately-held pre-revenue stage company developing radiofrequency balloon catheter technology. The Company's initial product, the ZCath System, has a CE Mark for use in reducing plaque in peripheral leg arteries. In November 2012, Vessix Vascular was acquired by Boston Scientific. The valuation of Vessix Vascular was $425 million. Other terms of the deal were not released.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.